Vera Therapeutics Inc - Ordinary Shares - Class A
VERA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.55B
Close$
$4.32
86.2% downside
Current Fair Value
86.2% downsideOvervalued by 86.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.55 Billion |
|---|---|
| Enterprise Value | $2.51 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.66 |
| Beta | 0.95 |
| Outstanding Shares | 71,476,595 |
Return
| Return on Equity | -73.84% |
|---|---|
| Return on Assets | -59.34% |
| Return on Invested Capital | -64.03% |
Valuation & Multiples
| P/E Ratio | -6.88 |
|---|---|
| PEG | -5.13 |
| Price to Sales | - |
| Price to Book Ratio | 5.21 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -6.8 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$-1.33
Average shareholder expectationRevenue Estimate
$426,033
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-1.60
Average shareholder expectationRevenue Estimate
$1.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0834▼ 17.64% |
|---|---|
| Total Calls | 1,016,200▲ 7.93% |
| Total Puts | 84,800▼ 65.33% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 112.46%▼ 3.46% |
|---|---|
| Total Invested | $2.92B▼ 22.13% |
| Investors Holding | 238▲ 15.00% |
ESG Score
No data
About Vera Therapeutics Inc
19 employees